Case Study
Use Of Real-World Evidence Expands To Transform Drug Development
Real-world evidence (RWE) provides a large and growing source of insights into drug uptake and safety. It is increasingly used in pricing and reimbursement negotiations and to support post-approval label expansions. RWE also has the potential to transform the efficiency and economics of drug development.